Purification of the Immunogenic Fractions and Determination of Toxicity in Mesobuthus eupeus (Scorpionida: Buthidae) Venom.

  • Mehdi Khoobdel Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Taghi Zahraei-Salehi Department of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Bahar Nayeri-Fasaei Department of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Mohammad Khosravi Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Zahra Omidian Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Mohammad Hassan Motedayen Razi Vaccine and Serum Research Institute-Karaj Branch, Karaj, Iran.
  • Abolfazal Akbari Razi Vaccine and Serum Research Institute-Karaj Branch, Karaj, Iran.
Keywords: Immunogenic, Mesobuthus eupeus, Scorpion, Toxicogenic, Venom

Abstract

Background: Scorpions stings are a health problem in many parts of the world. Mesobuthus eupeus (Buthidae) is the most prevalent species in the Middle East and Central Asia. Definition of toxicogenic and immunogenic characteris- tics of the venom is necessary to produce antidote. In this study, the noted properties of M. eupeus venom were eval- uated.Methods: Venom was obtained by milking M. eupeus scorpions for lyophilization. Toxicity was determined after injecting the venom to albino mice and calculating LD50. Polyclonal antibodies against M. eupeus venom were ob- tained from immunized rabbits. The CH-Sepharose 4B column was used for isolating the specific antibodies. 10 mg of the affinity-purified antibodies were conjugated with a CH-Sepharose 4B column and M. eupeus venom was ap- plied to the column. The bound fragments were eluted using hydrogen chloride (pH: 2.5). Crude venom and affinity- purified fractions of the venom were analyzed by SDS-PAGE technique.Results: Lethal dose (LD) was 8.75, 11.5 and 4.5 mg/kg for IP, SC and IV respectively. The LD50  of M. eupeus venom was 6.95 mg/kg. The crude venom had 12 detectable bands with molecular weights of 140, 70, 50, 33, 30, 27,22, 18, 14, 10 kDa and two bands less than 5 kDa. The affinity-purified venom presented eight bands. The 27 kDa band was clearly sharper than other bands but 70, 18, 10 and one of the less than 5 kDa bands were not observed. Conclusions: Contrary to popular belief, which know scorpion venom as non-immunogenic composition, the current study was shown that the most fractions of the M. eupeus are immunogenic.

References

Adiguzel S (2010) In vivo and in vitro ef- fects of scorpion venoms in Turkey: a mini-review. J Venom Anim Toxins incl Trop Dis. 16(2): 198–211.

Barona J, Otero R, Nunez V (2004) Toxico- logical and immunological aspects of scorpion venom (Tytius pachyurus), neu- tralizing capacity of antivenoms pro- duced in Latin America. Biomedica.24(1): 42–49.

Barral-Netto M, Vinhas V, Schriefer A, Barral A, Santos SB, Almeida AR, Novaes G (1991) Immunological studies with the venom of the scorpion Tityus serrulatus. Brazilian J Med Bio Res. 24(2): 171–180.

Bawaskar HS, Bawaskar PH (2012) Scor- pion sting: Update J Assoc Physicians India. 60(1): 46–55.

Borchani L, Sassi A, Yekhlef RB, Safra I, Ayeb ME (2011) Heminecrolysin, a poten- tial immunogen for monospecific anti- venom production against Hemiscorpius lepturus scorpion. Toxicon. 58(8): 681–688.

Boyer LV, Theodorou AA, Berg RA, Mallie J (2009) Antivenom for critically ill children with neurotoxicity from scorpion sting. N Engl J Med. 360: 2090–2098.

Calvete JJ (2010) Antivenomics and venom phenotyping: A marriage of conven- ience to address the performance and range of clinical use of antivenoms. Toxicon. 56(7): 1284–1291.

Chippaux JP, Goyffon M (2008) Epidemio- logy of scorpionism: A global app- raisal. Acta Trop. 107(2): 71–79.

Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T (2001) Characterization of unique am- phipathic antimicrobial peptides from venom of the scorpion Pandinus impe- rator. J Biochem. 359: 35–45.

Dehghani R, Fathi B (2012) Scorpion sting in Iran: A review, Toxicon, Available at: http://dx.doi.org/10.1016/j. toxicon.2012.06.002.

Dehghani R, Djadid ND, Shahbazzadeh D, Bigdelli S (2009) Introducing Comp- sobuthus matthiesseni (Birula, 1905) scorpion as one of the major stinging scorpions in Khuzestan, Iran. Toxicon.54(3): 272–275.

Dehghani R, Khamehchian T (2008) Scro- tum Injury by Scorpion Sting. J Ar- thropod-Borne Dis. 2(1): 49–52.

Duarte CG, Alvarenga LM, Lopes CD, Avila RA, Nguyen C, Molina F (2010) In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope. Vaccine. 28: 1168–1176.

El-Hafny B, Chgoury F, Adil N, Chen N, Nassar M (2002) Intraspecific variability and pharmacokinetics, characteristics of Androctonus mauretanicus scorpion venom. Toxicon. 40(11): 1609–1616.

Escoubas P, Corzo G, Whiteley BJ, Celerier ML, Nakajima T (2002) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and high-performance liquid chromatography study of quan- titative and qualitative variation in tarantula spider venoms. Rapid Commun

Mass Spectrom. 16(5): 403–413. Eskandari G, Khoonmirzaei AN (2011) Phylogenetic Analysis of Lysozyme C from the Scorpion Mesobuthus eupeus Venom Gland. J Bio Sci. 6(1): 9 –11.

Garcia C, Calderón-Aranda ES, Anguiano GA, Becerril B, Possani LD (2003) Analysis of the immune response induced by a scorpion venom sub-fraction, a pure pep- tide and a recombinant peptide, against toxin Cn2 of Centruroides noxius Hoff- mann. Toxicon. 41(4): 417–427.

Gazarian KG, Gazarian T, Hernández R, Possani LD (2005) Immunology of scorpion toxins and perspectives for generation of anti-venom vaccines. Vac- cine. 23(26): 3357–3368.

Gomase VS, Phadnis AC, Somnath W (2009) Proteomics based prediction of anti- genicity of iberiotoxin from eastern Indian scorpion. Inter J Drug Discov.1(1): 10–13.

Hassan F (1984) Production of scorpion antivenom. In: Tu A (ed) Handbook of Toxins, Insect Poisons, Allergens and other Invertebrates Venoms. Marcel Dekker, New York, pp. 577–605.

Inceoglua B, Langob J, Rabinovicha A, Whetstonea P, Hammock BD (2006) The neutralizing effect of a polyclonal antibody raised against the N-terminal eighteen-amino acid residues of bir- toxin towards the whole venom of Parabuthus transvaalicus. Toxicon. 47:144–149.

Kalapothakisa E, Jardima SA, Magalha˜esa C, Mendesa T, Marcoa L, De Afonsob, Chavez-Olo´rteguic LCC (2001) Screen- ing of expression libraries using ELISA: identification of immunogenic proteins from Tityus bahiensis and Tityus serrulatus venom. Toxicon. 39: 679–685.

Karatas A (2003) Mesobuthus eupeus (Koch,1839) (Scorpiones: Buthidae) in Ana- tolia. Euscorpius. 7: 1–7.

Keskin NA, Koc HA (2006) Study on venom proteins of Iurusdufoureius asiaticus Birula, 1903 (Scropiones: Iuridae). Acta Parasitol Turcica. 30(1): 60–62.

Laemmli K (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685.

March SC, Parikh I, Cuatrecasas P (1974) A simplified method for cyanogen bro- mide activation of agarose for affinity chromatography. Anal Biochem. 60(1):149–152.

National Ethics Advisory Committee (2006) Ethical Guidelines for Observational Studies: Observational research, audits and related activities. Ministry of Health, Wellington, New Zealand. Available at: http://www.newhealth.govt.nz/neac/.

Ozkan O, Ciftci G (2010) Individual varia- tion in the protein profile of the venom of Mesobuthus gibbosus (Brullé, 1832) (Scorpiones: Buthidae) from Turkey. J Venom Anim Toxins Incl Trop Dis.16(3): 505–508.

Ozkan O, Carhan A (2008) The neutralizing capacity of Androctonus crassicauda antivenom against Mesobuthus eupeus scorpion venom. Toxicon. 52: 375–79.

Ozkan O, Adiguzel S, Kar S, Kurt M, Yakistiran S, Cesaretli Y, Orman M, Karaer KZ (2007) Effects Of And- roctonus crassicauda (Olivier, 1807) (Scorpiones: Buthidae) venom on rats: correlation among acetyl cholinester- ase activities and electrolytes levels. J Venom Aanim Toxins Trop Dis. 13(1):69–81.

Pimenta AM, Almeida D, Delima MF, Eauclaire ME, Bougis PE (2003) Indi- vidual variability in Tityus serrulatus (Scorpiones, Buthidae) venom elicited by matrix-assisted laser desorption/ ionization time-of-flight mass spectrom- etry. Rapid Commun Mass Spectrom 2003. 17(5): 413–418.

Sadeghian H (2003) Transient ophtalmoplegia following envenomation by the scor- pion Mesobuthus eupeus. Neurology.60(2): 346–347.

Sagheb MM, Sharifian M, Moini M, Sharifian AH (2012) Scorpion bite prevalence and complications: report from a referral cen- tre in southern Iran. Trop Doct. 42(2):90–91.

Shirmardi SP, Shamsaei M, Gandomkar M, Saniei E, Ghannadi M, Zare A (2010) Comparison of two purified toxic fractions from Mesobuthus eupeus scorpion venom. J Venomous Animals Toxins include Trop Dis. 16(4): 639–646.

Tuuri RE, Reynolds S (2011) Scorpion en- venomation and antivenom therapy. Pediatr Emerg Care. 27(7): 667–672.

Ucar G, Tas C (2003) Cholin esterase inhib- itory activities of the scorpion Mes- obuthus gibbosus (Buthidae) venom pep- tides. FABAD J Pharm Sci. 28: 61–70.

Upadhyay RK, Ahmad S (2008) Isolation, pu- rification and characterization of venom toxins from Indian Red Scorpion, Mesobuthus Tamulus. J Cell Tissue Res.8(1): 1297–1302.

Warrell DA (2012) Venomous stings, stings, and poisoning. Infect Dis Clin North Am. 26(2): 207–223.

Zayerzadeh E, Koohi MK, ZareMirakabadi A, Fardipoor A, Kassaian SE, Rabbani S, Anvari MS (2012) Amelioration of cardio-respiratory perturbations follow- ing Mesobuthus eupeus envenomation in anesthetized rabbits with commercial polyvalent F(ab′)2 antivenom. Toxicon.59(2): 249–256.

How to Cite
1.
Khoobdel M, Zahraei-Salehi T, Nayeri-Fasaei B, Khosravi M, Omidian Z, Motedayen MH, Akbari A. Purification of the Immunogenic Fractions and Determination of Toxicity in Mesobuthus eupeus (Scorpionida: Buthidae) Venom. J Arthropod Borne Dis. 7(2):139-146.
Section
Articles